Monday, June 29, 2015 7:05:36 PM
The paper, “Assembly and Diploid Architecture of an Individual Human Genome via Single Molecule Technologies,” comes from a large team of collaborators at the Icahn School of Medicine at Mount Sinai, Cornell, Cold Spring Harbor Laboratory, and other institutions.
Their new approach leverages the best aspects of each single-molecule data type by combining long-read sequencing for de novo assembly with single-molecule genome maps for scaffolding. The resulting hybrid assembly represents a mix of SMRT® Sequencing data and single-molecule genome maps from BioNano Genomics’ NanoChannel Arrays.
The paper describes sequencing the well-studied NA12878 genome using SMRT Sequencing and generating single-molecule genome maps with nicking enzymes. “Individually, the assemblies and genome maps markedly improve contiguity and completeness compared with de novo assemblies from clone-free, short-read shotgun sequencing data,” the authors write. “Moreover, by combining the two platforms, we achieve scaffold N50 values greater than 28 Mb, improving the contiguity of the initial sequence assembly nearly 30-fold and of the initial genome map nearly 8-fold.”
The scientists then compared their assembly to the human reference genome to identify a comprehensive set of genetic variants, including a wide variety of larger structural variants that are often overlooked by short-read SBS approaches. The scientists note that while short-read technologies are frequently used to survey genomes to identify single nucleotide variants, they cannot resolve most large-scale genetic variation, including a wide variety of structural variants and repetitive regions that confound short-read assemblies.
“Though the cost of sequencing has markedly decreased, de novo human genome analysis has, to some extent, regressed,” the authors report. “Although HuRef and the original Celera whole-genome shotgun assembly have scaffold N50 values … of 19.5 Mb and 29 Mb respectively, the best next-generation sequencing (NGS) assemblies have scaffold N50 values of 11.5 Mb, even with the use of high-coverage fosmid jumping libraries.” The biggest challenges in these short-read assemblies, they add, are repetitive structures, transposable elements, segmental duplications, and heterochromatin.
Advantages of this extraordinary contiguity in their single-molecule assembly, to which short-read NGS data was later added, include detecting large structural variants and successfully phasing both single nucleotide and structural variants. Comparisons of the assembly to reference genomes allowed the team to resolve and phase structural variants such as tandem repeats across the genome. They successfully separated maternal and paternal alleles, revealing complex events that had been missed in previous assemblies.
For structural elements, the authors report that “a major benefit of continuous long reads is the ability to directly observe structural variants,” an approach they say is more effective than relying on breakpoint analysis or local realignment.
The combination of SMRT Sequencing data, genome maps, and NGS data “allowed us to resolve long-standing assembly discrepancies,” the scientists write. http://blog.pacificbiosciences.com/2015/06/nature-methods-paper-uses-long-read.html
Recent PACB News
- Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases • PR Newswire (US) • 05/15/2024 01:45:00 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 05/09/2024 08:33:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:21:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:12:15 PM
- PacBio Announces First Quarter 2024 Financial Results • PR Newswire (US) • 05/09/2024 08:05:00 PM
- PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance • PR Newswire (US) • 04/16/2024 12:05:00 PM
- Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes • PR Newswire (US) • 03/27/2024 12:00:00 PM
- PacBio Grants Equity Incentive Award to New Employee • PR Newswire (US) • 03/22/2024 08:30:00 PM
- PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions • PR Newswire (US) • 03/12/2024 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:36:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:30:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:26:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:22:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:32:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:22:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:55:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:36:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:25:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:19:42 PM
- PacBio to Present at Upcoming Investor Conferences • PR Newswire (US) • 02/26/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:25:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:17:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:07:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 09:17:12 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM